In spite of a great amount of data reflecting the SMN2 gene copy number impact on SMA phenotype, progression, and therapeutic outcomes, there are numerous discrepant cases that provide evidences of more complicated pathways involved in regulation of SMA pathogenesis. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.